UNSPSC 51402302: Enciprazine

This classification denotes an anxiolytic with the molecular formula C23H32N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, L6X660925G chemically known as (+/-)-1-(3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl)-4-(2-methoxyphenyl)piperazine but generally known as enciprazine, which bears US NIH Compound Identifier 50222. European Medicines Agency schedules Enciprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06520MIG.

UNSPSC 51402302 Enciprazine is a Commodity code that in recent state and local procurement appears to span pharmaceutical products and medical countermeasures, though the single available opportunity shows active buying of naloxone and drug deactivation systems rather than enciprazine specifically. State and local health departments and county health authorities are the primary issuing bodies under this code, procuring medical supplies and pharmaceuticals to support public health initiatives, emergency response, and community health programs. The scope includes acquisition of finished pharmaceutical products and related medical devices delivered on regular schedules, with vendors typically required to meet standard compliance certifications such as drug-free workplace status and E-Verify confirmation.

Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. The contract includes a two-year initial term with an option for one-year renewal, fixed-fee pricing, and compliance with federal regulations due to potential FEMA funding. Beyond this single recent opportunity, the code shows limited recent visibility in state and local procurement activity, suggesting either narrow application or infrequent solicitation cycles for enciprazine or closely related pharmaceutical commodities at the state and local level.